Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S32–42.
Google Scholar
Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197–213.
Google Scholar
Han E, Han KD, Lee YH, Kim KS, Hong S, Park JH, Park CY. Fatty liver and diabetes statistics in Korea: nationwide data 2009 to 2017. Diabetes Metab J. 2023;47(3):347–55.
Google Scholar
Kim JY, Lee J, Moon JH, Park SE, Ko SH, Choi SH, Kim NH. Prevalence, incidence, and metabolic characteristics of young adults with type 2 diabetes mellitus in South Korea (2010–2020). Diabetes Metab J. 2025;49(2):172–82.
Google Scholar
Stefan N, Yki-Jarvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134–48.
Google Scholar
Stefan N, Targher G. Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine. Nat Rev Gastroenterol Hepatol. 2025;22(4):226–7.
Google Scholar
Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina RM, Alvarez M, Gelev K, Maurotti S, Vespasiani-Gentilucci U, et al. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024;30(12):3614–23.
Google Scholar
Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U, Qadri SF, Caiazzo R, Verkindt H, Saponaro C, et al. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024;30(12):3624–33.
Google Scholar
Alkhouri N, Hanouneh IA, Zein NN, Lopez R, Kelly D, Eghtesad B, Fung JJ. Liver transplantation for nonalcoholic steatohepatitis in young patients. Transpl Int. 2016;29(4):418–24.
Google Scholar
Han E, Lee YH, Kim YD, Kim BK, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, et al. Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk. Am J Gastroenterol. 2020;115(4):584–95.
Google Scholar
Jung I, Koo DJ, Lee WY. Insulin resistance, non-alcoholic fatty liver disease and type 2 diabetes mellitus: clinical and experimental perspective. Diabetes Metab J 2024; 48: 327.
Google Scholar
Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus—mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612.
Google Scholar
Stefan N, Schick F, Birkenfeld AL, Haring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35(2):236–52.
Google Scholar
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542–56.
Google Scholar
Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Mortality in metabolic dysfunction-associated steatotic liver disease: a nationwide population-based cohort study. Metabolism. 2024;152:155789.
Google Scholar
Park H, Yoon EL, Cho S, Jun DW, Nah EH. Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease. Gut. 2022;71(5):1035–6.
Google Scholar
Han E, Han KD, Lee BW, Kang ES, Cha BS, Ko SH, Lee YH. Severe hypoglycemia increases dementia risk and related mortality: a nationwide, population-based cohort study. J Clin Endocrinol Metab. 2022;107(5):e1976–86.
Google Scholar
Kim KS, Kim B, Han K. Big data research for diabetes-related diseases using the Korean National health information database. Diabetes Metab J. 2025;49(1):13–21.
Google Scholar
Han E, Lee JY, Han KD, Cho H, Kim KJ, Lee BW, Kang ES, Cha BS, Younossi ZM, Lee YH. Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes. Sci Rep. 2020;10(1):6800.
Google Scholar
Kim MK, Han K, Lee SH. Current trends of big data research using the Korean National health information database. Diabetes Metab J. 2022;46(4):552–63.
Google Scholar
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
Google Scholar
Perazzo H, Pacheco AG, Griep RH. Collaborators: changing from NAFLD through MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort. J Hepatol. 2024;80(2):e72–4.
Google Scholar
Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201–4.
Google Scholar
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, et al. 2023 clinical practice guidelines for diabetes management in Korea: full version recommendation of the Korean diabetes association. Diabetes Metab J. 2024;48(4):546–708.
Google Scholar
Jeong SM, Jeon KH, Shin DW, Han K, Kim D, Park SH, Cho MH, Lee CM, Nam KW, Lee SP. Smoking cessation, but not reduction, reduces cardiovascular disease incidence. Eur Heart J. 2021;42(40):4141–53.
Google Scholar
Kimm H, Yun JE, Lee SH, Jang Y, Jee SH. Validity of the diagnosis of acute myocardial infarction in Korean National medical health insurance claims data: the Korean heart study (1). Korean Circ J. 2012;42(1):10–5.
Google Scholar
WHO. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: International Diabetes Institute, Regional Office for the Western Pacific; 2000.
Park SE, Ko SH, Kim JY, Kim K, Moon JH, Kim NH, Han KD, Choi SH, Cha BS. Diabetes fact sheets in Korea 2024. Diabetes Metab J. 2025;49(1):24–33.
Google Scholar
Bae J, Han E, Lee HW, Park CY, Chung CH, Lee DH, Cho EH, Rhee EJ, Yu JH, Park JH, et al. Metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus: a review and position statement of the fatty liver research group of the Korean diabetes association. Diabetes Metab J. 2024;48(6):1015–28.
Google Scholar
Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962–9.
Google Scholar
Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2018;41(2):372–82.
Google Scholar
Bae JC, Han JM, Cho JH, Kwon H, Park SE, Park CY, Lee WY, Oh KW, Kwon S, Park SW, et al. The persistence of fatty liver has a differential impact on the development of diabetes: the Kangbuk Samsung health study. Diabetes Res Clin Pract. 2018;135:1–6.
Google Scholar
Fukuda T, Hamaguchi M, Kojima T, Mitsuhashi K, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Eur J Gastroenterol Hepatol. 2016;28(12):1443–9.
Google Scholar
Sung KC, Wild SH, Byrne CD. Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab. 2013;98(9):3637–43.
Google Scholar
Yamazaki H, Tsuboya T, Tsuji K, Dohke M, Maguchi H. Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes. Diabetes Care. 2015;38(9):1673–9.
Google Scholar
Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58(11):1538–44.
Google Scholar
Simon TG, Roelstraete B, Hartjes K, Shah U, Khalili H, Arnell H, Ludvigsson JF. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. J Hepatol. 2021;75(5):1034–41.
Google Scholar
Kaikkonen JE, Wurtz P, Suomela E, Lehtovirta M, Kangas AJ, Jula A, Mikkila V, Viikari JS, Juonala M, Ronnemaa T, et al. Metabolic profiling of fatty liver in young and middle-aged adults: cross-sectional and prospective analyses of the young Finns study. Hepatology. 2017;65(2):491–500.
Google Scholar
Han E, Lee YH. Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metab J. 2017;41(6):430–7.
Google Scholar
Kim D, Wijarnpreecha K, Cholankeril G, Ahmed A. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024;80(2):e79–81.
Google Scholar
Kim KS, Hong S, Ahn HY, Park CY. Metabolic dysfunction-associated fatty liver disease and mortality: a population-based cohort study. Diabetes Metab J. 2023;47(2):220–31.
Google Scholar
Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024;384:e076388.
Google Scholar